The Holladay Journal is the local newspaper covering news and events in the city of Holladay, Utah. The Holladay Journal provides one of the best advertising channels to the residents of the city of Holladay. Holladayjournal.com is the online lead...

Holladay Journal | Educating | Entertaining | Informing

CK Life Sciences’ Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer

HONG KONG SAR -  Media OutReach Newswire - 18 May 2026 - Sequencio Therapeutics, a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences", Stock Code: 0775) today announced the appointment of Emily Tan as Chief Operating Officer. A 30-year biopharmaceutical veteran, Ms Tan will oversee the company's global operations and drive execution across its development pipeline. 
  Ms Tan joins Sequencio Therapeutics with an extensive track record across global pharmaceutical companies, leading contract research organisations, and innovative biotechnology companies, bringing deep expertise in clinical development, operations, quality, regulatory execution, and commercial strategy. 
  Ms Tan most recently served as Senior Vice President, Business Development at IQVIA, where she led commercial activities in Asia Pacific and supported clients in developing and executing global integrated go-to-market strategies. 
  Her career includes C-suite roles at China-based biotech startups Unixell Biotechnology, Bennu Biotherapeutics, and Oricell Therapeutics, where she scaled operations and led successful global Investigational New Drug (IND) and China Investigator-Initiated Trial (IIT) submissions. She previously held leadership positions at PAREXEL, Syneos and Pfizer. 
  "Emily brings a rare combination of operational excellence, clinical development experience, and regional and global leadership," said Dr Melvin Toh, Vice President and Chief Scientific Officer of CK Life Sciences. "Her appointment strengthens Sequencio Therapeutics' leadership team as we advance our pipeline and build the operational foundation to support our next stage of growth." 
  "I am excited to join the Sequencio Therapeutics team at this important stage of its development," said Ms Tan. "Building on the company's strong scientific foundation, I look forward to strengthening operational capabilities and supporting the continued advancement of the pipeline." 
  Ms Tan holds a Bachelor of Science in Pharmacy (Honours) from the National University of Singapore and a Master of Science in Epidemiology from the London School of Hygiene and Tropical Medicine. 
Hashtag: #CKLifeSciences #Sequencio #Therapeutics #COO #ChiefOperatingOfficer #CancerVaccines #R&D #Pharmaceutical #Biotechnology
The issuer is solely responsible for the content of this announcement.

Sequencio Therapeutics Company Limited
Sequencio Therapeutics Company Limited, a subsidiary of CK Life Sciences Int'l., (Holdings) Inc., is focused on developing next‑generation therapeutic cancer vaccines that harness a patient's own immune system to achieve durable, long‑term remission with a favourable safety profile, addressing key limitations of current standard‑of‑care therapies. Sequencio Therapeutics is driven by a long‑term vision to shift cancer treatment from transient tumour reduction toward sustained, immune‑controlled remission.

Toobit

Toobit Brings 36% APR on TON to Expanding High-Yield Earn Series

UK Tea and Infusions Association

First Sips: How Tea Becomes A Lifelong Habit For Brits Says The UK Tea And Infusions Association (UKTIA)

How CPA Tax Advisors Help NY Earners Get More From Every Income Stream

Ike's Air Conditioning Inc. Addresses AC Installation Timing Challenges

World Platinum Investment Council (WPIC)

Fourth consecutive platinum market deficit forecast for 2026 - supply to fall short of demand by 297 koz

Sohu.com Limited

SOHU.COM REPORTS FIRST QUARTER 2026 UNAUDITED FINANCIAL RESULTS

Wego

Wego and Ras Al Khaimah Tourism Development Authority Partner to Inspire Experience-Led Travel through RAK Moments

Meowant

Meowant Introduces Meowant Self-Cleaning Cat Litter Box – MW-SC09

The extra-large smart litter box features a spacious 106L interior, low-entry open design, 360° smart safety protection, app-based health monitoring, and advanced odor control for cleaner, easier care in single- and multi-cat homes

The Publicity Department of Beichen District

At north China's Jinmen Qianchengyan, century-old industrial heritage takes on Chinese culinary charm

Bitcoin Depot Inc.

Bitcoin Depot Initiates Voluntary Chapter 11 Process to Facilitate an Orderly Wind-Down and Sale of the Company’s Assets

Labbit

Labbit Introduces Validation Assistant as the Latest Addition to Its Change Management Lifecycle for Regulated Laboratories

SINOPEC

Exclusively Sponsored by Sinopec's Aipao Racing Fuel, the 2026 China Taklimakan Rally Kicks Off in Urumqi

Rockefeller Foundation

Rockefeller Foundation Awarded US$350M+ to Reach 731 Million People Amid 2025's Historic Decline in Global Aid

Air Clinic Addresses Rising AC Failures During Texas Power Demand

Blue Morpho Highlights Emerging Research on Shamanic Healing in Peru

NovalGen Ltd.

NovalGen Appoints Dr Laurent Fischer as Chair of the Board

Cloud Native Computing Foundation

CNCF Welcomes CVS Health as a Platinum Member To Expand Cloud Native Collaboration

Renaissance Water

Renaissance Water advances to XPRIZE Water Scarcity semifinals; announces industry partners and test site